Pharmaceutical Executive
An overview of Orphan Reinsurer and Benefit Managers groups, including potential challenges with the model and various model suggestions.
Gregory L. Warren
Advertisement
Articles by Gregory L. Warren
Advertisement
Latest Updated Articles
Improving Management of Gene and Cell TherapiesSeptember 10th 2018
Advertisement
Advertisement
Trending on PharmExec
1
New Study Reveals Genetic Predictors for GLP-1 Weight Loss and Side Effects
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
Amgen’s Tarlatamab Approved in China
4
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
5